ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1313

The Role of Tryptophan and Its Metabolites in Risk for Incident Hip Fractures and Frailty: The Cardiovascular Health Study

Laura Carbone1, Petra Bůžková2, John Robbins3, Howard Fink4, Joshua Barzilay5, Rachel Elam1 and Carlos Isales1, 1Augusta University, Augusta, GA, 2University of Washington, Seattle, WA, 3UC Davis, Davis, CA, 4University of Minnesota, Minneapolis, MN, 5Kaiser Permanente, Atlanta, GA

Meeting: ACR Convergence 2022

Keywords: Fracture, osteoporosis

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2022

Title: Osteoporosis and Metabolic Bone Disease – Basic and Clinical Science Poster

Session Type: Poster Session C

Session Time: 1:00PM-3:00PM

Background/Purpose: Essential amino acids including tryptophan (trp) are building blocks for protein, and adequate protein intake is important for skeletal homeostasis. In experimental studies, trp increases bone formation. However, particularly with aging, trp is susceptible to oxidative modification, and oxidative stress is associated with osteoporosis. We sought to determine whether serum levels of trp and its oxidized and nonoxidized metabolites were risk factors for hip fracture and frailty.

Methods: We included participants within the Cardiovascular Health Study (CHS), a longitudinal study of community-dwelling adults aged 65 years and older from four U.S. sites. We selected participants from years 1992-1993 (year five of CHS) for whom stored serum was available and for whom there was complete information on relevant covariates. We included 131 individuals who sustained a hip fracture during the following twelve years of follow-up and 131 participants without an incident hip fracture over these following twelve years of follow- up (controls). Individuals were weighted by sex, race and hip fracture status to represent the whole CHS population at year 5. Measurements of trp and its metabolites were performed using liquid chromatograph-mass spectrometry analyses. Cox hazard models with robust standard errors were used to estimate the association of trp and its metabolites with hip fractures censoring at the first hip fracture event, death, loss of follow up or after 12 years of follow-up. Relative risk regression was done to evaluate the cross sectional association of trp and its metabolites with frailty using Freid’s index with categories defined as frail vs. not frail and prefrail vs. frail. False discovery rate approach was used to adjust p values for multiple testing for secondary exposures. The primary exposure was trp; trp metabolites were secondary exposures.

Results: Higher serum levels of trp were significantly inversely associated with risk of incident hip fractures (Table 1) There were no statistically significant associations between the oxidized or nonoxidized products of trp with incident hip fractures (Tables 1 and 2) or with frailty status (frail vs. not frail) or with prefrail vs. not frail status (p >0.05 for both).

Conclusion: Trp, but not its metabolites, was significantly associated with less risk for incident hip fractures in older adults. Neither trp nor any of its metabolites was significantly associated with frailty. Prospective cohort studies are needed to estimate what difference in trp intake is associated with an absolute difference in incident hip fractures to design a future randomized clinical trial.

Supporting image 1

Table 1. Association of Trp and its Metabolites with Hip Fractures

Supporting image 2

Table 2. Association of Oxidation Status of Trp Metabolites with Hip Fractures


Disclosures: L. Carbone, None; P. Bůžková, None; J. Robbins, None; H. Fink, None; J. Barzilay, None; R. Elam, None; C. Isales, None.

To cite this abstract in AMA style:

Carbone L, Bůžková P, Robbins J, Fink H, Barzilay J, Elam R, Isales C. The Role of Tryptophan and Its Metabolites in Risk for Incident Hip Fractures and Frailty: The Cardiovascular Health Study [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/the-role-of-tryptophan-and-its-metabolites-in-risk-for-incident-hip-fractures-and-frailty-the-cardiovascular-health-study/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-role-of-tryptophan-and-its-metabolites-in-risk-for-incident-hip-fractures-and-frailty-the-cardiovascular-health-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology